

A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC $1,014,746 Financing | Newest SEC Filings

















Newest Filings











A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC $1,014,746 Financing
A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC just submitted form D announcing $1,014,746 financing.  This is a new filing. A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC was able to sell $1,014,746. That is 100% of the round of financing. The total private offering amount was $1,014,746. The financing was made by 59 investors. Minimal accepted investment was $1,000. The financing document was filed on 2016-12-15. A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC is based in  PO BOX 171305  SALT LAKE CITY 84117. The firm's business is Pooled Investment Fund. The form was signed by  LLC Assure Fund Management.





SEC FORM D


The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.



UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM DNotice of Exempt Offering of Securities


OMB APPROVAL


OMB Number:
3235-0076

Estimated average burden

hours per response:
4.00






1. Issuer's Identity


CIK (Filer ID Number)
Previous Names

X
None

Entity Type


0001687339




  
Corporation


  
Limited Partnership


X
Limited Liability Company


  
General Partnership


  
Business Trust


  
Other (Specify)





Name of Issuer
A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization


  
Over Five Years Ago


X
Within Last Five Years (Specify Year)
2016


  
Yet to Be Formed



2. Principal Place of Business and Contact Information

Name of Issuer
A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC

Street Address 1
Street Address 2

2150 S. 1300 E. Suite 360

City
State/Province/Country
ZIP/PostalCode
Phone Number of Issuer


SALT LAKE CITY
UTAH
84106
8017133508


3. Related Persons


Last Name
First Name
Middle Name


Assure Fund Management
LLC


Street Address 1
Street Address 2

PO Box 171305

City
State/Province/Country
ZIP/PostalCode


Salt Lake City
UTAH
84117



Relationship:
  
Executive Officer
X
Director
  
Promoter

Clarification of Response (if Necessary):
Issuer's Manager


Last Name
First Name
Middle Name


Neilson
Jeremy


Street Address 1
Street Address 2

PO Box 171305

City
State/Province/Country
ZIP/PostalCode


Salt Lake City
UTAH
84117



Relationship:
X
Executive Officer
  
Director
  
Promoter

Clarification of Response (if Necessary):
Managing Director of the Issuer's Manager


Last Name
First Name
Middle Name


Johnson
Mateo


Street Address 1
Street Address 2

PO Box 171305

City
State/Province/Country
ZIP/PostalCode


Salt Lake City
UTAH
84117



Relationship:
X
Executive Officer
  
Director
  
Promoter

Clarification of Response (if Necessary):
Officer of the Issuer's Manager
4. Industry Group



  
Agriculture



Banking & Financial Services





  
Commercial Banking


  
Insurance


  
Investing


  
Investment Banking


X
Pooled Investment Fund





  
Hedge Fund


  
Private Equity Fund


  
Venture Capital Fund


X
Other Investment Fund





Is the issuer registered as an investment company under the Investment Company Act of 1940? 




  
Yes
X
No



  
Other Banking & Financial Services




  
Business Services



Energy




  
Coal Mining





  
Electric Utilities





  
Energy Conservation





  
Environmental Services





  
Oil & Gas





  
Other Energy






Health Care




  
Biotechnology





  
Health Insurance





  
Hospitals & Physicians





  
Pharmaceuticals





  
Other Health Care



  
Manufacturing



Real Estate




  
Commercial





  
Construction





  
REITS & Finance





  
Residential





  
Other Real Estate





  
Retailing


  
Restaurants



Technology




  
Computers





  
Telecommunications





  
Other Technology




Travel




  
Airlines & Airports





  
Lodging & Conventions





  
Tourism & Travel Services





  
Other Travel



  
Other



5. Issuer Size










Revenue Range
OR
Aggregate Net Asset Value Range


  
No Revenues
  
No Aggregate Net Asset Value


  
$1 - $1,000,000
  
$1 - $5,000,000


  
$1,000,001 - $5,000,000
  
$5,000,001 - $25,000,000


  
$5,000,001 - $25,000,000
  
$25,000,001 - $50,000,000


  
$25,000,001 - $100,000,000
  
$50,000,001 - $100,000,000


  
Over $100,000,000
  
Over $100,000,000


  
Decline to Disclose
X
Decline to Disclose


  
Not Applicable
  
Not Applicable



6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)



  
Rule 504(b)(1) (not (i), (ii) or (iii))


  
Rule 504 (b)(1)(i)


  
Rule 504 (b)(1)(ii)


  
Rule 504 (b)(1)(iii)


  
Rule 505


  
Rule 506(b)


X
Rule 506(c)


  
Securities Act Section 4(a)(5)




X
Investment Company Act Section 3(c)


X
Section 3(c)(1)
  
Section 3(c)(9)  


  
Section 3(c)(2)
  
Section 3(c)(10)


  
Section 3(c)(3)
  
Section 3(c)(11)


  
Section 3(c)(4)
  
Section 3(c)(12)


  
Section 3(c)(5)
  
Section 3(c)(13)


  
Section 3(c)(6)
  
Section 3(c)(14)


  
Section 3(c)(7)



7. Type of Filing


X
New Notice

Date of First Sale
2016-12-06

  
First Sale Yet to Occur


  
Amendment


8. Duration of Offering

Does the Issuer intend this offering to last more than one year?


  
Yes
X
No


9. Type(s) of Securities Offered (select all that apply)









  
Equity
X
Pooled Investment Fund Interests


  
Debt
  
Tenant-in-Common Securities


  
Option, Warrant or Other Right to Acquire Another Security
  
Mineral Property Securities


  
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
  
Other (describe)







10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?


  
Yes
X
No


Clarification of Response (if Necessary):
11. Minimum Investment

Minimum investment accepted from any outside investor

$1,000

USD

12. Sales Compensation


Recipient

Recipient CRD Number
X
None




(Associated) Broker or Dealer
X
None


(Associated) Broker or Dealer CRD Number
X
None



Street Address 1
Street Address 2


City
State/Province/Country
ZIP/Postal Code



State(s) of Solicitation (select all that apply)Check “All States” or check individual States
  
All States


  
Foreign/non-US



13. Offering and Sales Amounts


Total Offering Amount

$1,014,746

USD

or
  
Indefinite



Total Amount Sold

$1,014,746

USD


Total Remaining to be Sold

$0

USD

or
  
Indefinite



Clarification of Response (if Necessary):
14. Investors


  
Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.




Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
59


15. Sales Commissions & Finder's Fees Expenses
Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.


Sales Commissions

$0

USD

  
Estimate



Finders' Fees

$0

USD

  
Estimate



Clarification of Response (if Necessary):
16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.



$8,000

USD

  
Estimate


Clarification of Response (if Necessary):
This amount represents a one-time fixed cost to cover fund organizational and operating expenses, including all regulatory filing fees.Signature and Submission
Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.
Terms of Submission

In submitting this notice, each issuer named above is:

Notifying the SEC and/or each State in which this notice is filed of the offering of 
                    securities described and undertaking to furnish them, upon written request, in the accordance with applicable
                    law, the information furnished to offerees.*
Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator 
                    or other legally designated officer of the State in which the issuer maintains its principal 
                    place of business and any State in which this notice is filed, as its agents for service of 
                    process, and agreeing that these persons may accept service on its behalf, of any notice, 
                    process or pleading, and further agreeing that such service may be made by registered or 
                    certified mail, in any Federal or state action, administrative proceeding, or arbitration 
                    brought against it in any place subject to the jurisdiction of the United States, if the 
                    action, proceeding or arbitration (a) arises out of any activity in connection with the 
                    offering of securities that is the subject of this notice, and (b) is founded, directly or 
                    indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange 
                    Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the 
                    Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) 
                    the laws of the State in which the issuer maintains its principal place of business or any State 
                    in which this notice is filed.
Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Regulation D for one of the reasons stated in Rule 505(b)(2)(iii) or Rule 506(d).


Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.
For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.


Issuer
Signature
Name of Signer
Title
Date


A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC
Mateo Johnson
Mateo Johnson
Officer of the Issuer's Manager
2016-12-14


Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
* This undertaking does not affect any limits Section 102(a) of the National Securities Markets
        Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to
        require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes 
        of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot
        routinely require offering materials under this undertaking or otherwise and can require offering materials only to the
        extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.




A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC Financing

DateFiling TypeOfferedSoldRemainingMin. investmentInvest. countExemption / Exlusions
2016-12-15New Form D$1,014,746$1,014,7460$1,0005906c 3C 3C.1[view]
A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC List of ExecutivesJeremy Neilson, LLC Assure Fund Management, Mateo Johnson











Last visited: Aurora Offshore Fund Ltd, Aurora Global Opportunities L P, Aurora Hedged Equity L P, Aurora Hedged Equity Offshore Fund Ltd, Aurora Limited Partnership II

								© 
							
















A-PCR-28-Fund, a series of AngelList-GP-Funds, LLC Reg D SEC Securities Filing | Disclosure Quest

















← Back to search


    Currently Viewing:
    
DocumentHTML
0001687339-16-000001.txt




Link to this page



Tweet this filing 


URL copied to clipboard



    Unfortunately, there is no HTML record of this filing.
  





















 













 




A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC $146,999 Financing | Newest SEC Filings

















Newest Filings











A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC $146,999 Financing
A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC just submitted form D announcing $146,999 financing.  This is a new filing. A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC was able to sell $146,999. That is 100% of the round of financing. The total private offering amount was $146,999. The financing was made by 41 investors. Minimal accepted investment was $1,000. The financing document was filed on 2017-06-15. A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC is based in  PO BOX 171305  SALT LAKE CITY 84117. The firm's business is Pooled Investment Fund. The form was signed by  LLC Assure Fund Management.





SEC FORM D


The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.



UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM DNotice of Exempt Offering of Securities


OMB APPROVAL


OMB Number:
3235-0076

Estimated average burden

hours per response:
4.00






1. Issuer's Identity


CIK (Filer ID Number)
Previous Names

X
None

Entity Type


0001708022




  
Corporation


  
Limited Partnership


X
Limited Liability Company


  
General Partnership


  
Business Trust


  
Other (Specify)





Name of Issuer
A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization


  
Over Five Years Ago


X
Within Last Five Years (Specify Year)
2017


  
Yet to Be Formed



2. Principal Place of Business and Contact Information

Name of Issuer
A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC

Street Address 1
Street Address 2

2150 S. 1300 E., Suite 360

City
State/Province/Country
ZIP/PostalCode
Phone Number of Issuer


Salt Lake City
UTAH
84106
(801) 713-3508


3. Related Persons


Last Name
First Name
Middle Name


Assure Fund Management
LLC


Street Address 1
Street Address 2

PO Box 171305

City
State/Province/Country
ZIP/PostalCode


Salt Lake City
UTAH
84117



Relationship:
  
Executive Officer
X
Director
  
Promoter

Clarification of Response (if Necessary):
Issuer's Manager


Last Name
First Name
Middle Name


Johnson
Mateo


Street Address 1
Street Address 2

PO Box 171305

City
State/Province/Country
ZIP/PostalCode


Salt Lake City
UTAH
84117



Relationship:
X
Executive Officer
  
Director
  
Promoter

Clarification of Response (if Necessary):
Officer of the Issuer's Manager


Last Name
First Name
Middle Name


Neilson
Jeremy


Street Address 1
Street Address 2

PO Box 171305

City
State/Province/Country
ZIP/PostalCode


Salt Lake City
UTAH
84117



Relationship:
X
Executive Officer
  
Director
  
Promoter

Clarification of Response (if Necessary):
Managing Director of the Issuer's Manager
4. Industry Group



  
Agriculture



Banking & Financial Services





  
Commercial Banking


  
Insurance


  
Investing


  
Investment Banking


X
Pooled Investment Fund





  
Hedge Fund


  
Private Equity Fund


  
Venture Capital Fund


X
Other Investment Fund





Is the issuer registered as an investment company under the Investment Company Act of 1940? 




  
Yes
X
No



  
Other Banking & Financial Services




  
Business Services



Energy




  
Coal Mining





  
Electric Utilities





  
Energy Conservation





  
Environmental Services





  
Oil & Gas





  
Other Energy






Health Care




  
Biotechnology





  
Health Insurance





  
Hospitals & Physicians





  
Pharmaceuticals





  
Other Health Care



  
Manufacturing



Real Estate




  
Commercial





  
Construction





  
REITS & Finance





  
Residential





  
Other Real Estate





  
Retailing


  
Restaurants



Technology




  
Computers





  
Telecommunications





  
Other Technology




Travel




  
Airlines & Airports





  
Lodging & Conventions





  
Tourism & Travel Services





  
Other Travel



  
Other



5. Issuer Size










Revenue Range
OR
Aggregate Net Asset Value Range


  
No Revenues
  
No Aggregate Net Asset Value


  
$1 - $1,000,000
  
$1 - $5,000,000


  
$1,000,001 - $5,000,000
  
$5,000,001 - $25,000,000


  
$5,000,001 - $25,000,000
  
$25,000,001 - $50,000,000


  
$25,000,001 - $100,000,000
  
$50,000,001 - $100,000,000


  
Over $100,000,000
  
Over $100,000,000


  
Decline to Disclose
X
Decline to Disclose


  
Not Applicable
  
Not Applicable



6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)



  
Rule 504(b)(1) (not (i), (ii) or (iii))


  
Rule 504 (b)(1)(i)


  
Rule 504 (b)(1)(ii)


  
Rule 504 (b)(1)(iii)


  
Rule 505


X
Rule 506(b)


  
Rule 506(c)


  
Securities Act Section 4(a)(5)




X
Investment Company Act Section 3(c)


X
Section 3(c)(1)
  
Section 3(c)(9)  


  
Section 3(c)(2)
  
Section 3(c)(10)


  
Section 3(c)(3)
  
Section 3(c)(11)


  
Section 3(c)(4)
  
Section 3(c)(12)


  
Section 3(c)(5)
  
Section 3(c)(13)


  
Section 3(c)(6)
  
Section 3(c)(14)


  
Section 3(c)(7)



7. Type of Filing


X
New Notice

Date of First Sale
2017-06-09

  
First Sale Yet to Occur


  
Amendment


8. Duration of Offering

Does the Issuer intend this offering to last more than one year?


  
Yes
X
No


9. Type(s) of Securities Offered (select all that apply)









  
Equity
X
Pooled Investment Fund Interests


  
Debt
  
Tenant-in-Common Securities


  
Option, Warrant or Other Right to Acquire Another Security
  
Mineral Property Securities


  
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
  
Other (describe)







10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?


  
Yes
X
No


Clarification of Response (if Necessary):
11. Minimum Investment

Minimum investment accepted from any outside investor

$1,000

USD

12. Sales Compensation


Recipient

Recipient CRD Number
X
None




(Associated) Broker or Dealer
X
None


(Associated) Broker or Dealer CRD Number
X
None



Street Address 1
Street Address 2


City
State/Province/Country
ZIP/Postal Code



State(s) of Solicitation (select all that apply)Check “All States” or check individual States
  
All States


  
Foreign/non-US



13. Offering and Sales Amounts


Total Offering Amount

$146,999

USD

or
  
Indefinite



Total Amount Sold

$146,999

USD


Total Remaining to be Sold

$0

USD

or
  
Indefinite



Clarification of Response (if Necessary):
14. Investors


  
Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.




Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
41


15. Sales Commissions & Finder's Fees Expenses
Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.


Sales Commissions

$0

USD

  
Estimate



Finders' Fees

$0

USD

  
Estimate



Clarification of Response (if Necessary):
16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.



$8,000

USD

  
Estimate


Clarification of Response (if Necessary):
This amount represents a one-time fixed cost to cover fund organizational and operating expenses, including all regulatory filing fees.Signature and Submission
Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.
Terms of Submission

In submitting this notice, each issuer named above is:

Notifying the SEC and/or each State in which this notice is filed of the offering of 
                    securities described and undertaking to furnish them, upon written request, in the accordance with applicable
                    law, the information furnished to offerees.*
Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator 
                    or other legally designated officer of the State in which the issuer maintains its principal 
                    place of business and any State in which this notice is filed, as its agents for service of 
                    process, and agreeing that these persons may accept service on its behalf, of any notice, 
                    process or pleading, and further agreeing that such service may be made by registered or 
                    certified mail, in any Federal or state action, administrative proceeding, or arbitration 
                    brought against it in any place subject to the jurisdiction of the United States, if the 
                    action, proceeding or arbitration (a) arises out of any activity in connection with the 
                    offering of securities that is the subject of this notice, and (b) is founded, directly or 
                    indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange 
                    Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the 
                    Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) 
                    the laws of the State in which the issuer maintains its principal place of business or any State 
                    in which this notice is filed.
Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Regulation D for one of the reasons stated in Rule 505(b)(2)(iii) or Rule 506(d).


Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.
For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.


Issuer
Signature
Name of Signer
Title
Date


A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC
Mateo Johnson
Mateo Johnson
Officer of the Issuer's Manager
2017-06-15


Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
* This undertaking does not affect any limits Section 102(a) of the National Securities Markets
        Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to
        require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes 
        of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot
        routinely require offering materials under this undertaking or otherwise and can require offering materials only to the
        extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.




A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC Financing

DateFiling TypeOfferedSoldRemainingMin. investmentInvest. countExemption / Exlusions
2017-06-15New Form D$146,999$146,9990$1,0004106b 3C 3C.1[view]
A-JFH-13-Fund, a series of AngelList-GP-Funds, LLC List of ExecutivesJeremy Neilson, LLC Assure Fund Management, Mateo Johnson











Last visited: Capital Group Emerging Markets Restricted Equity Common Trust (US), SCB Global Opportunities Fund, LP, Sante Health Ventures I Annex Fund, LP, SCB Global Opportunities Offshore Fund, Ltd., Capital Group Emerging Markets US Dollar Debt Common Trust (US)

								© 
							
















ANGELLIST-VOLTEM2-FUND, A SERIES OF ANGELLIST-GP-FUNDS, LLC Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      ANGELLIST-VOLTEM2-FUND, A SERIES OF ANGELLIST-GP-FUNDS, LLC
                    

•   SALT LAKE CITY, UT
                      
How do I update this listing?




                                             Angellist-voltem2-fund, A Series OF Angellist-gp-funds is based out of Salt Lake City.    The firm last filed a Form D notice of exempt offering of securities on 2014-08-28. The filing was for a pooled investment fund:  other investment fund The notice  included securities offered of Pooled Investment Fund Interests
                                           














Summary
13D/G
Insider (Form 4)
Form D 1



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from ANGELLIST-VOLTEM2-FUND, A SERIES OF ANGELLIST-GP-FUNDS, LLC, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




angellist-voltem2-fund, a series of angellist-gp-funds, llc


PO BOX 171305

SALT LAKE CITY
UT
                                                        
                                                    84117


                                                      Business Phone:
                                                      8017133508







Recent SEC Filings




D filed on 08/28/2014
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...



Form D Filings

  Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission.
  Form D contains basic information about the offering and the company.


Form D Filings


Filing Date
Form Type
Industry Group
Securities Offered
Total Offering Amount
Total Amount Sold
Total Remaining




2014-08-28
D
POOLED INVESTMENT FUND:  OTHER INVESTMENT FUND

      Pooled Investment Fund Interests
    
662,000
662,000
0




Other Issuers in Filings


Name
Address





  No Other Issuers
  




Related Parties included in filings


Name
Address
Relationship




JEREMY   NEILSON

          subscription required
    


          EXECUTIVE OFFICER
      



LLC   ASSURE FUND MANAGEMENT,

          subscription required
    


          DIRECTOR
      











Elevate your investments
Try it for free



















Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














AngelList - Where the world meets startups
































































Join
 
Log In







AngelList


Startup Jobs

Recruit

Invest

More





Companies

Freelancers

Incubators

Track

Salaries
Valuations

Help











Your Alumni Network








Companies

Freelancers

Incubators

Track

Salaries
Valuations

Help


















 



Where the world meets startups


 
Find a Startup Job

Post a Job

Invest in Startups



 













Get a Job at a Startup


Apply privately to 68,093 startup jobs with one application

No middlemen
·
See salary and equity upfront



Find a Job
Post a Job







Uber







Niantic









Houseparty (Life on Air)







DuckDuckGo









Crunchbase







Stripe












Join the Professional Investor Program


Full name



Email



Phone number



Location



Type of entity

Single Family Office
Multi-Family Office
Venture Investor
Institution
Financial Advisor
Other

Name of your firm or fund



Your role



Annual budget for startup investing



Personal Message















Invest in Startups


Build a diverse portfolio of early-stage startup investments

Private and oversubscribed deals






Deal-by-deal Investments


Invest alongside notable lead investors to access top deals


Learn More »






Invest in a Startup Fund


One investment gets you exposure to 100+ startups


View Details »






Professional Investors


For family offices, institutions and financial professionals


Request Access »





RECENT EXITS







Ticketbis


ACQUIRED BY
EBAY









Cruise Automation


ACQUIRED BY
GENERAL MOTORS












Browse jobs by role

Data Scientist jobs
Designer jobs
Developer jobs
Frontend Developer jobs
Hardware Engineer jobs


Human Resources jobs
Marketing jobs
Mobile Developer jobs
Product Manager jobs
Sales jobs





Browse jobs by location

Austin jobs
Boston jobs
Chicago jobs
Colorado jobs
India jobs


London jobs
Los Angeles jobs
New York jobs
Seattle jobs
Silicon Valley jobs










Founded by AngelList Alumni





Now anyone can invest in startups through the
Republic equity crowdfunding platform




View crowdfunding companies












Help
·
Directory
·
Blog
Twitter
·
Terms & Risks
·
Unsubscribe

·
Mobile



·
Desktop


·
Photo Credit











 - Pooled Investment Fund  FormDs.com - SEC filings of fundraisings and investments in hedge funds, private equity firms, startups, and growing companies 











 FormDs.com 





 Newest
 Filter
 Local




 









Industry Filter
Agriculture
Airlines and Airports
Biotechnology
Business Services
Coal Mining
Commercial
Commercial Banking
Computers
Construction
Electric Utilities
Energy Conservation
Environmental Services
Health Insurance
Hospitals and Physicians
Insurance
Investing
Investment Banking
Lodging and Conventions
Manufacturing
Oil and Gas
Other
Other Banking and Financial Services
Other Energy
Other Health Care
Other Real Estate
Other Technology
Other Travel
Pharmaceuticals
Pooled Investment Fund
REITS and Finance
Residential
Restaurants
Retailing
Telecommunications
Tourism and Travel Services



Company
New Filing?
Reported funding
Incremental Cash 
Date
New or Amended




WM Capital Partners 61, LLC
(Pooled Investment Fund)

Yes
$7,550,000
$7,550,000
2017-07-25
New Filing



CV Industry II, LLC
(Pooled Investment Fund)

Yes
$2,000,000
$2,000,000
2017-07-25
New Filing



CV II Protect, LLC
(Pooled Investment Fund)

Yes
$850,000
$850,000
2017-07-25
New Filing



Meta Stable Edge Offshore Fund, Ltd.
(Pooled Investment Fund)

No
$2,100,000
$2,100,000
2017-07-25
Amended



Foundry Mezzanine Opportunity Fund, LP
(Pooled Investment Fund)

No
$13,898,100
$7,283,100
2017-07-25
Amended



Love Alexander Fund, LP
(Pooled Investment Fund)

No
$2,605,000
$2,605,000
2017-07-24
Amended



TenOneTen Ventures II, L.P.
(Pooled Investment Fund)

Yes
Yet to Sell
$0
2017-07-24
New Filing



PCH Manager Fund, SPC-Segregated Portfolio 211
(Pooled Investment Fund)

Yes
$80,640,000
$80,640,000
2017-07-24
New Filing



SaaStr Opportunity Fund I, L.P.
(Pooled Investment Fund)

Yes
$17,790,000
$17,790,000
2017-07-24
New Filing



Sprott Private Resource Lending (C-Co-Invest), LP
(Pooled Investment Fund)

Yes
$31,000,000
$31,000,000
2017-07-24
New Filing



BLUE HERON PARTNERS L P
(Pooled Investment Fund)

No
$41,338,141
$10,546,094
2017-07-24
Amended



GHP INTERNATIONAL REFORM & DEVELOPMENT FUND L P
(Pooled Investment Fund)

Yes
$5,200,000
$5,200,000
2017-07-24
New Filing



FJ Labs REB LLC
(Pooled Investment Fund)

Yes
$795,000
$795,000
2017-07-24
New Filing



CREA Partners II, L.P.
(Pooled Investment Fund)

Yes
Yet to Sell
$0
2017-07-24
New Filing



LiveOak Venture Partners II, L.P.
(Pooled Investment Fund)

Yes
Yet to Sell
$0
2017-07-24
New Filing



Canaan XI L.P.
(Pooled Investment Fund)

Yes
Yet to Sell
$0
2017-07-24
New Filing



Performance EFFEM PE Fund, L.P.: Series 2017
(Pooled Investment Fund)

Yes
$134,000,000
$134,000,000
2017-07-24
New Filing



SAYA Partners LP
(Pooled Investment Fund)

Yes
$15,000,000
$15,000,000
2017-07-24
New Filing



Oak Street Emerging Manager U1A, LP
(Pooled Investment Fund)

Yes
$101,010,101
$101,010,101
2017-07-24
New Filing



PHRONESIS PARTNERS L P
(Pooled Investment Fund)

No
$27,646,734
$1,459,000
2017-07-24
Amended



OurCrowd (Investment in Wave) LP
(Pooled Investment Fund)

Yes
$149,995
$149,995
2017-07-24
New Filing



SSC Venture Partners LLC
(Pooled Investment Fund)

Yes
$155,000
$155,000
2017-07-24
New Filing



CREEK LANE REAL ESTATE FUND I, LP
(Pooled Investment Fund)

Yes
$57,000,000
$57,000,000
2017-07-24
New Filing



Celadon Technology Fund V, LLC
(Pooled Investment Fund)

No
$12,356,606
$260,526
2017-07-24
Amended



Hosking Partners Equity Fund LLC
(Pooled Investment Fund)

Yes
$27,000,000
$27,000,000
2017-07-24
New Filing



ASB ALLEGIANCE REAL ESTATE FUND, LP
(Pooled Investment Fund)

No
$3,095,716,773
$582,648,697
2017-07-24
Amended



Orchard Hill Intermediate Fund LP
(Pooled Investment Fund)

No
$172,251,290
$0
2017-07-24
Amended



Orchard Hill Domestic Fund LP
(Pooled Investment Fund)

No
$71,498,710
$0
2017-07-24
Amended



PATRIOT FINANCIAL PARTNERS III, L.P.
(Pooled Investment Fund)

Yes
$128,225,000
$128,225,000
2017-07-24
New Filing



Sancta Value Fund US LP
(Pooled Investment Fund)

No
$8,200,000
$6,187,254
2017-07-24
Amended



← Previous 1 2 3 4 5 6 7 8 9 Next →










Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft














Region Selector - Kapa Biosystems





















































Change Region
Login
Cart
My Account
Contact Us
 
















Change Region
Login
Cart
My Account
Contact Us
 
Products & Applications

Applications

Next Generation Sequencing

Whole Genome
RNA Sequencing
Targeted Sequencing
FFPE Sample Sequencing
ChIP Sequencing
Methyl Sequencing
Epigenetics
Automated Solutions


qPCR

Gene Expression
Mouse Genotyping
Food and Water Safety Testing


PCR

Colony PCR
High-fidelity PCR
Fast PCR
Sanger Sequencing
Single-protocol PCR
Genotyping
Cloning
Crude Sample PCR
GC-rich PCR
Mutagenesis
Long-range PCR
Direct Blood PCR
Direct Plant PCR
Multiplex PCR




Products

Next Generation Sequencing

Sample QC
DNA Library Preparation
Library Amplification
RNA Library Preparation
Library Quantification
Beads


qPCR

KAPA SYBR® FAST
KAPA SYBR FAST One-Step
KAPA PROBE FORCE
KAPA PROBE FAST
KAPA HRM FAST


PCR

KAPA HiFi
KAPA HiFi Uracil+
KAPA2G Robust
KAPA2G Fast Multiplex
KAPA3G Plant
KAPA2G Fast
KAPA Mouse Genotyping
KAPA Long Range
KAPA Blood
KAPA Taq
KAPA Express Extract
KAPA DNA Ladders
KAPA dNTPs
KAPA T4 DNA Ligase
KAPA Rapid Ligation System




Platforms

Illumina® Platforms
Ion Torrent™ Platform


Promotions
Request a Trial Kit


Technology

Directed Evolution


Resources

Document Library
Technical Data Sheet Search
Scientific Tools and Guides
Publications
Webinars


Support

Scientific Support
Order Support
Certificate of Analysis Requests


Community

Blog
Customer Testimonials
Social Media Hub


Company

About Us
Leadership Team
Custom and OEM Solutions
Careers
News
Events
Brand Assets and Usage


 


 



Region Selector




United States





Canada





Latin & South America





Europe, Africa & Middle East





Asia Pacific





Japan




With the acquisition of Kapa Biosystems by Roche and the recent distribution agreement with Sigma Aldrich, online purchasing has changed as of January 1st 2017.


                            If you are in the U.S., you can continue to purchase directly from kapabiosystems.com.
                        

                            For our customers outside of the U.S., you may continue to browse the website and research products, and if interested in purchasing, you will have an option to continue on to the distributor website.
                        

You may continue to browse the website and research products, and if interested in purchasing, you will have an option to continue on to the distributor website.
Please see below for details.
Note: If you do not have an existing account with Sigma-Aldrich or Nippon (Japan only), you will need to sign up for a new online account and/or complete a new customer application and credit approval.




NGS (including KAPA HiFi
                                    and KAPA HiFi Uracil+)
PCR/qPCR








US


                                Buy direct at kapabiosystems.com
No change.
                                Buy direct at kapabiosystems.com



Canada

Contact Roche Sales
Visit Sigma-Aldrich



Worldwide





Latin America:
Contact Roche Sales
Visit Sigma-Aldrich


Europe, Middle East and Africa:
Contact Roche Sales
Visit Sigma-Aldrich


Asia-Pacific:
Contact Roche Sales
Visit Sigma-Aldrich



Japan:

Contact Roche Sales
Contact Roche Sales










You will be now redirected to regional web site for .
Cancel




Sigma (APAC/EMEA/LATAM) / NIPPON Genetics Ltd. (Japan only).
Close




Show Modal Popup with this Message: Contact Regional Roche Sales: or Sigma Aldrich
Close





If this is your first time logging in to the updated site, you will need to reset your password.

Please click "Lost your password?", and an email will be sent to you to update your credentials.

Username or email *



Password *








 Remember me


Register
Lost your password?


























Region Selector - Kapa Biosystems





















































Change Region
Login
Cart
My Account
Contact Us
 
















Change Region
Login
Cart
My Account
Contact Us
 
Products & Applications

Applications

Next Generation Sequencing

Whole Genome
RNA Sequencing
Targeted Sequencing
FFPE Sample Sequencing
ChIP Sequencing
Methyl Sequencing
Epigenetics
Automated Solutions


qPCR

Gene Expression
Mouse Genotyping
Food and Water Safety Testing


PCR

Colony PCR
High-fidelity PCR
Fast PCR
Sanger Sequencing
Single-protocol PCR
Genotyping
Cloning
Crude Sample PCR
GC-rich PCR
Mutagenesis
Long-range PCR
Direct Blood PCR
Direct Plant PCR
Multiplex PCR




Products

Next Generation Sequencing

Sample QC
DNA Library Preparation
Library Amplification
RNA Library Preparation
Library Quantification
Beads


qPCR

KAPA SYBR® FAST
KAPA SYBR FAST One-Step
KAPA PROBE FORCE
KAPA PROBE FAST
KAPA HRM FAST


PCR

KAPA HiFi
KAPA HiFi Uracil+
KAPA2G Robust
KAPA2G Fast Multiplex
KAPA3G Plant
KAPA2G Fast
KAPA Mouse Genotyping
KAPA Long Range
KAPA Blood
KAPA Taq
KAPA Express Extract
KAPA DNA Ladders
KAPA dNTPs
KAPA T4 DNA Ligase
KAPA Rapid Ligation System




Platforms

Illumina® Platforms
Ion Torrent™ Platform


Promotions
Request a Trial Kit


Technology

Directed Evolution


Resources

Document Library
Technical Data Sheet Search
Scientific Tools and Guides
Publications
Webinars


Support

Scientific Support
Order Support
Certificate of Analysis Requests


Community

Blog
Customer Testimonials
Social Media Hub


Company

About Us
Leadership Team
Custom and OEM Solutions
Careers
News
Events
Brand Assets and Usage


 


 



Region Selector




United States





Canada





Latin & South America





Europe, Africa & Middle East





Asia Pacific





Japan




With the acquisition of Kapa Biosystems by Roche and the recent distribution agreement with Sigma Aldrich, online purchasing has changed as of January 1st 2017.


                            If you are in the U.S., you can continue to purchase directly from kapabiosystems.com.
                        

                            For our customers outside of the U.S., you may continue to browse the website and research products, and if interested in purchasing, you will have an option to continue on to the distributor website.
                        

You may continue to browse the website and research products, and if interested in purchasing, you will have an option to continue on to the distributor website.
Please see below for details.
Note: If you do not have an existing account with Sigma-Aldrich or Nippon (Japan only), you will need to sign up for a new online account and/or complete a new customer application and credit approval.




NGS (including KAPA HiFi
                                    and KAPA HiFi Uracil+)
PCR/qPCR








US


                                Buy direct at kapabiosystems.com
No change.
                                Buy direct at kapabiosystems.com



Canada

Contact Roche Sales
Visit Sigma-Aldrich



Worldwide





Latin America:
Contact Roche Sales
Visit Sigma-Aldrich


Europe, Middle East and Africa:
Contact Roche Sales
Visit Sigma-Aldrich


Asia-Pacific:
Contact Roche Sales
Visit Sigma-Aldrich



Japan:

Contact Roche Sales
Contact Roche Sales










You will be now redirected to regional web site for .
Cancel




Sigma (APAC/EMEA/LATAM) / NIPPON Genetics Ltd. (Japan only).
Close




Show Modal Popup with this Message: Contact Regional Roche Sales: or Sigma Aldrich
Close





If this is your first time logging in to the updated site, you will need to reset your password.

Please click "Lost your password?", and an email will be sent to you to update your credentials.

Username or email *



Password *








 Remember me


Register
Lost your password?


























Region Selector - Kapa Biosystems





















































Change Region
Login
Cart
My Account
Contact Us
 
















Change Region
Login
Cart
My Account
Contact Us
 
Products & Applications

Applications

Next Generation Sequencing

Whole Genome
RNA Sequencing
Targeted Sequencing
FFPE Sample Sequencing
ChIP Sequencing
Methyl Sequencing
Epigenetics
Automated Solutions


qPCR

Gene Expression
Mouse Genotyping
Food and Water Safety Testing


PCR

Colony PCR
High-fidelity PCR
Fast PCR
Sanger Sequencing
Single-protocol PCR
Genotyping
Cloning
Crude Sample PCR
GC-rich PCR
Mutagenesis
Long-range PCR
Direct Blood PCR
Direct Plant PCR
Multiplex PCR




Products

Next Generation Sequencing

Sample QC
DNA Library Preparation
Library Amplification
RNA Library Preparation
Library Quantification
Beads


qPCR

KAPA SYBR® FAST
KAPA SYBR FAST One-Step
KAPA PROBE FORCE
KAPA PROBE FAST
KAPA HRM FAST


PCR

KAPA HiFi
KAPA HiFi Uracil+
KAPA2G Robust
KAPA2G Fast Multiplex
KAPA3G Plant
KAPA2G Fast
KAPA Mouse Genotyping
KAPA Long Range
KAPA Blood
KAPA Taq
KAPA Express Extract
KAPA DNA Ladders
KAPA dNTPs
KAPA T4 DNA Ligase
KAPA Rapid Ligation System




Platforms

Illumina® Platforms
Ion Torrent™ Platform


Promotions
Request a Trial Kit


Technology

Directed Evolution


Resources

Document Library
Technical Data Sheet Search
Scientific Tools and Guides
Publications
Webinars


Support

Scientific Support
Order Support
Certificate of Analysis Requests


Community

Blog
Customer Testimonials
Social Media Hub


Company

About Us
Leadership Team
Custom and OEM Solutions
Careers
News
Events
Brand Assets and Usage


 


 



Region Selector




United States





Canada





Latin & South America





Europe, Africa & Middle East





Asia Pacific





Japan




With the acquisition of Kapa Biosystems by Roche and the recent distribution agreement with Sigma Aldrich, online purchasing has changed as of January 1st 2017.


                            If you are in the U.S., you can continue to purchase directly from kapabiosystems.com.
                        

                            For our customers outside of the U.S., you may continue to browse the website and research products, and if interested in purchasing, you will have an option to continue on to the distributor website.
                        

You may continue to browse the website and research products, and if interested in purchasing, you will have an option to continue on to the distributor website.
Please see below for details.
Note: If you do not have an existing account with Sigma-Aldrich or Nippon (Japan only), you will need to sign up for a new online account and/or complete a new customer application and credit approval.




NGS (including KAPA HiFi
                                    and KAPA HiFi Uracil+)
PCR/qPCR








US


                                Buy direct at kapabiosystems.com
No change.
                                Buy direct at kapabiosystems.com



Canada

Contact Roche Sales
Visit Sigma-Aldrich



Worldwide





Latin America:
Contact Roche Sales
Visit Sigma-Aldrich


Europe, Middle East and Africa:
Contact Roche Sales
Visit Sigma-Aldrich


Asia-Pacific:
Contact Roche Sales
Visit Sigma-Aldrich



Japan:

Contact Roche Sales
Contact Roche Sales










You will be now redirected to regional web site for .
Cancel




Sigma (APAC/EMEA/LATAM) / NIPPON Genetics Ltd. (Japan only).
Close




Show Modal Popup with this Message: Contact Regional Roche Sales: or Sigma Aldrich
Close





If this is your first time logging in to the updated site, you will need to reset your password.

Please click "Lost your password?", and an email will be sent to you to update your credentials.

Username or email *



Password *








 Remember me


Register
Lost your password?





















